NCT Number: NCT02364687
Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging
Detecting scarred heart muscle is important to diagnose and treat of a wide variety of heart conditions. Magnetic resonance imaging (MRI) can assess scarred heart muscle but it is time consuming, contraindicated for some patients and not tolerated by others. Computed tomography (CT) imaging has the potential to provide a rapid comprehensive assessment of the heart. This study will assess CT imaging of the heart muscle of patients who have previously undergone MRI of their heart. Using a state of the art CT scanner the investigators will develop a low radiation dose protocol to identify scarred heart muscle. The investigators will use and develop software techniques to analyse these images. This will enable us to develop a new way to identify and measure scarred heart muscle that will benefit patients with heart disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
40 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Presence of late enhancement on magnetic resonance imaging
Exclusion criteria
- age less than 40
- inability or unwillingness to undergo CT
- renal failure (serum creatinine >200 umol/l or estimated glomerular filtration rate <30 ml/min)
- hepatic failure
- allergy to iodinated contrast
- pregnancy
- breast feeding
- inability to undergo informed consent
- fast atrial fibrillation
Treatment and study plan
Primary outcomes
-
Myocardial late enhancement
Time frame: Immediate
The amount of myocardial late enhancement measured on computed tomography as compared to magnetic resonance imaging.
Sponsors and collaborators
Lead sponsor
University of Edinburgh
Other
Registry information
Official study title
Optimisation and Quantification of Contrast Enhanced Computed Tomography
Important dates
- Study start
- 2013
- Primary completion
- 2015
- Study completion
- 2023
- First posted
- Feb 18, 2015
- Registry last updated
- Jun 27, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Women's Health Initiative Strong and Healthy Study
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsCES1 Crossover Trial of Clopidogrel and Ticagrelor
NCT03161678
Cardiovascular Diseases, Embolism and Thrombosis
Lancaster, Pennsylvania, United States
View Trial DetailsMental Stress and Myocardial Ischemia After MI: Sex Differences, Mechanisms and Prognosis
NCT04123197
Cardiovascular Diseases, Heart Diseases
Atlanta, Georgia, United States
View Trial DetailsImproving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details